You are here

Article Text

Article menu
Download PDFPDF
Therapeutics/Prevention
Systematic review
Type 2 diabetes mellitus screening has no effect on mortality
  1. Uzung Yoon
  1. Department of Anesthesiology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA
  1. Correspondence to : Dr Uzung Yoon, Department of Anesthesiology, Thomas Jefferson University Hospital, 111 S. 11th Street, Suite 8290 Gibbon, Philadelphia, PA 19107, USA; uzyoon{at}gmail.com

https://doi.org/10.1136/ebmed-2015-110225

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Selph S, Dana T, Blazina I, et al. Screening for type 2 diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2015; 162:765–6.OpenUrlCrossRefPubMed

    Context

    Screening for type 2 diabetes mellitus in asymptomatic persons could lead to early identification and treatment, and potentially result in improved outcomes. In 2008, the U.S. Preventive Services Task Force (USPSTF) recommended diabetes screening in asymptomatic adults with sustained blood pressure (BP) greater than 135/80 mm Hg. Unfortunately, the USPSTF found insufficient evidence to assess the balance of benefits and harms of screening adults without elevated BP. Some evidence supports the use of impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) in identifying high-risk populations.1 Lifestyle and drug interventions in these groups showed beneficial effects for …

    View Full Text

    Footnotes

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.